Bryophyllum pinnatum (syn. Kalanchoe pinnata), a plant native to Madagascar, was introduced into anthroposophic medicine in the early 20th century. In recent years, a number of investigations were conducted on the chemical composition, pharmacological properties, and clinical efficacy of Bryophyllum. Here the phytochemistry, and pharmacological and clinical data are reviewed. With respect to pharmacology, a special focus was put on properties related to the use in anthroposophic medicine as a treatment for "hyperactivity diseases", including preterm labor, restlessness, and sleep disorders. Recent studies suggest that B. pinnatum has also potential as a treatment option in patients suffering from overactive bladder syndrome. Tolerability of Bryophyllum is addressed, and existing toxicological data are discussed in relation to bufadienolides contained in Bryophyllum. Open questions regarding the use of Bryophyllum are also discussed.
CITATION STYLE
Hamburger, M., Potterat, O., Fürer, K., Simões-Wüst, A. P., & Von Mandach, U. (2017). Bryophyllum pinnatum - Reverse engineering of an anthroposophic herbal medicine. In Natural Product Communications (Vol. 12, pp. 1359–1364). Natural Product Incorporation. https://doi.org/10.1177/1934578x1701200847
Mendeley helps you to discover research relevant for your work.